We have an unwavering commitment to keep our patients safe. But staffing shortages can make it challenging to check on your patients as often as you’d like.
What if you could monitor patients from anywhere in the hospital — and never miss a thing? Now you can, with the the RespArray™ patient monitor.
It's designed to continuously monitor patients in areas of care where spot checking might not be enough or where additional parameters are needed — for example, in medical-surgical units or for capnography use in procedural sedation. So you can detect respiratory compromise early and intervene sooner.
The RespArray™ patient monitor features simple connectivity and seamlessly integrates into workflow. So you’ll have more time to focus on your patients.
On average, medical-surgical registered nurses spend 96% of their shift away from the patient's bedside.1
Experience world-class Nellcor™ pulse oximetry and Microstream™ capnography technologies, designed to detect respiratory compromise early — and help reduce alarm fatigue.
The Smart Alarm for Respiratory Analysis™ (SARA) in Microstream™ technology reduces unneccessary nuisance alarms by 53%.2
Your dedicated white-glove service team is with you every step of the way. Customizable plans and service options are tailored to fit your needs.
Average amount that continuous monitoring of high-risk patients may help a median-sized hospital save annually3,†
The measurements provided through the RespArray™ patient monitor, including Nellcor™, Microstream™, and other vital signs, should not be used as the sole basis for diagnosis or therapy and are intended only as adjuncts to patient assessment.
*Vital Sync ™ platform v3.3 connectivity to RespArray has not been cleared by the FDA and is being released per FDA's Enforcement Policy for Non-Invasive Monitoring Devices Used to Support Patient Monitoring During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised), updated October 2020.
†This assumes a 20% respiratory depression reduction and an annual general care floor volume of 2,447 patients receiving opioids per median-sized hospital. 90% of surgical patients and 45% of medical patients on U.S. general care floors receive opioids. Continuous pulse oximetry and capnography device pricing assumptions used list pricing for the following: a Capnostream™ 35 portable respiratory monitor prorated over 7 years; a Microstream™ capnography filter line, and a disposable Nellcor™ pulse oximetry sensor, resulting in $52.73 in device costs per continuously monitored patient stay on a medical surgical floor. For intermittent pulse oximetry monitoring, device pricing consisted of a multiparameter monitor prorated over 7 years and a reusable pulse oximetry sensor, resulting in $0.68 in device costs per patient stay. Additional information on pricing and assumptions are available in the study publication.
1. Hendrich A, Chow M, Skierczynski B, Lu Z. A 36-hospital time and motion study: how do medical-surgical nurses spend their time? Perm J. 2008; 12(3):25-34.
2. Hockman S, Glembot T, Niebel K. Comparison of capnography derived respiratory rate alarm frequency using the SARA algorithm versus an established non-adaptive respiratory rate alarm management algorithm in bariatric surgical patients. Resp Care. 2009 open forum abstract; December 2009.
3. Khanna A, Junquist C, Buhre W, Soto R, di Piazza F, Saager L. Modeling the cost savings of continuous pulse oximetry and capnography monitoring of United States general care floor patients receiving opioids based on the PRODIGY trial. Adv Ther. 2021 May 24:1–15.